Evidence map›Paper›PMID 33749664›Full record

ArticleJCI insight2021

Leukocyte dynamics after intracerebral hemorrhage in a living patient reveal rapid adaptations to tissue milieu.

Brittany A Goods, Michael H Askenase, Erica Markarian, Hannah E Beatty, Riley S Drake, Ira Fleming, Jonathan H DeLong, Naomi H Philip, Charles C Matouk, Issam A Awad and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. FOXO1-driven metabolic reprogramming of hematomal CD8Cellular & molecular immunology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Brittany A GoodsDepartment of Chemistry and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Michael H AskenaseDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
Erica MarkarianKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Hannah E BeattyDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
Riley S DrakeDepartment of Chemistry and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Ira FlemingDepartment of Chemistry and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Jonathan H DeLongDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
Naomi H PhilipDepartment of Immunobiology and.
Charles C MatoukDepartment of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.
Issam A AwadDepartment of Neurosurgery, University of Chicago, Chicago, Illinois, USA.
Mario ZuccarelloDepartment of Neurosurgery, University of Cincinnati, Cincinnati, Ohio, USA.
Daniel F HanleyBrain Injury Outcomes Division, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
J Christopher LoveBroad Institute, Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Alex K ShalekDepartment of Chemistry and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Lauren H SansingDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
ICHseq Investigators
Yale University · USBroad Institute · USMassachusetts Institute of Technology · USJohns Hopkins University · USUniversity of Chicago · USUniversity of Cincinnati · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Angela Nicole Koehler · 1985 to 2026
$93.9M
Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN SupplementU24TR001609 · NCATS · JOHNS HOPKINS UNIVERSITY · PI HANLEY, DANIEL F · 2016 to 2022
$36.3M
MISTIE III_ Lead Grant_ Cluster Application for the Clinical Coordinating CenterU01NS080824 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HANLEY, DANIEL F · 2013 to 2017
$23.2M
Dynamic Neuroimmune Profiling in Patients with Acute Intracerebral HemorrhageR01NS097728 · NINDS · YALE UNIVERSITY · PI SANSING, LAUREN H · 2016 to 2020
$2.8M
An integrated multiplexed genomic assay for low input clinical samples1U24AI118672 · NIAID · BROAD INSTITUTE, INC. · PI SHALEK, ALEX K · 2015 to 2019
$2.0M
Characterizing spatio-temporal changes in immune cell landscapes of multiple sclerosis patients in response to B cell depletion with OcrelizumabF32AI136459 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GOODS, BRITTANY ANNE · 2018 to 2020
$184k
NCATS NIH HHS U24 TR001609NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA014051NIAID NIH HHS F32 AI136459NIAID NIH HHS U24 AI118672NINDS NIH HHS R01 NS097728NINDS NIH HHS U01 NS080824
6 · The paper itself

Abstract

Intracerebral hemorrhage (ICH) is a devastating form of stroke with a high mortality rate and few treatment options. Discovery of therapeutic interventions has been slow given the challenges associated with studying acute injury in the human brain. Inflammation induced by exposure of brain tissue to blood appears to be a major part of brain tissue injury. Here, we longitudinally profiled blood and cerebral hematoma effluent from a patient enrolled in the Minimally Invasive Surgery with Thrombolysis in Intracerebral Hemorrhage Evacuation trial, offering a rare window into the local and systemic immune responses to acute brain injury. Using single-cell RNA-Seq (scRNA-Seq), this is the first report to our knowledge that characterized the local cellular response during ICH in the brain of a living patient at single-cell resolution. Our analysis revealed shifts in the activation states of myeloid and T cells in the brain over time, suggesting that leukocyte responses are dynamically reshaped by the hematoma microenvironment. Interestingly, the patient had an asymptomatic rebleed that our transcriptional data indicated occurred prior to detection by CT scan. This case highlights the rapid immune dynamics in the brain after ICH and suggests that sensitive methods such as scRNA-Seq would enable greater understanding of complex intracerebral events.

Indexed as

Adaptation, PhysiologicalAgedCerebral HemorrhageFemaleGenomicsHumansLeukocytesMinimally Invasive Surgical ProceduresTomography, X-Ray ComputedImmunologyNeuroscienceStroke

Identifiers

PMID33749664
PMCPMC8026179
OpenAlexW3138611894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.